TNFRSF10A and cancer: Coincidentally, augmented TRAIL sensitivity was found in cisplatin-resistant cancer cell lines due to redistribution of DR4 and various components of the death inducing signaling complex (DISC) to the lipid raft subdomains of plasma membrane [29].